Novel pyridazinone inhibitors for vascular adhesion protein-1 (VAP-1): old target-new inhibition mode.

Vascular adhesion protein-1 (VAP-1) is a primary amine oxidase and a drug target for inflammatory and vascular diseases. Despite extensive attempts to develop potent, specific, and reversible inhibitors of its enzyme activity, the task has proven challenging. Here we report the synthesis, inhibitory activity, and molecular binding mode of novel pyridazinone inhibitors, which show specificity for VAP-1 over monoamine and diamine oxidases. The crystal structures of three inhibitor-VAP-1 complexes show that these compounds bind reversibly into a unique binding site in the active site channel. Although they are good inhibitors of human VAP-1, they do not inhibit rodent VAP-1 well. To investigate this further, we used homology modeling and structural comparison to identify amino acid differences, which explain the species-specific binding properties. Our results prove the potency and specificity of these new inhibitors, and the detailed characterization of their binding mode is of importance for further development of VAP-1 inhibitors.

[1]  S. Jalkanen,et al.  VAP-1: an adhesin and an enzyme. , 2001, Trends in immunology.

[2]  Zbyszek Otwinowski,et al.  Diffraction data analysis in the presence of radiation damage , 2010, Acta crystallographica. Section D, Biological crystallography.

[3]  G. Murshudov,et al.  Refinement of macromolecular structures by the maximum-likelihood method. , 1997, Acta crystallographica. Section D, Biological crystallography.

[4]  J Mitchell Guss,et al.  Structure and inhibition of human diamine oxidase. , 2009, Biochemistry.

[5]  Tiina Salminen,et al.  Carbohydrates located on the top of the “cap” contribute to the adhesive and enzymatic functions of vascular adhesion protein‐1 , 2005, European journal of immunology.

[6]  Jack Snoeyink,et al.  Nucleic Acids Research Advance Access published April 22, 2007 MolProbity: all-atom contacts and structure validation for proteins and nucleic acids , 2007 .

[7]  Zbyszek Otwinowski,et al.  The many faces of radiation-induced changes. , 2007, Journal of synchrotron radiation.

[8]  Jinsheng Chen,et al.  Structure-based optimization of a potent class of arylamide FMS inhibitors. , 2008, Bioorganic & medicinal chemistry letters.

[9]  S. Jalkanen,et al.  Ectoenzymes controlling leukocyte traffic , 2012, European journal of immunology.

[10]  J. Newman,et al.  A new crystal form of human vascular adhesion protein 1. , 2010, Acta crystallographica. Section F, Structural biology and crystallization communications.

[11]  Wladek Minor,et al.  Measurement errors and their consequences in protein crystallography. , 2003, Acta crystallographica. Section D, Biological crystallography.

[12]  Z. Dauter,et al.  Identification of patterns in diffraction intensities affected by radiation exposure. , 2013, Journal of synchrotron radiation.

[13]  E J Dodson,et al.  Collaborative Computational Project, number 4: providing programs for protein crystallography. , 1997, Methods in enzymology.

[14]  A. Weiss,et al.  Structure and activity of Aspergillus nidulans copper amine oxidase. , 2011, Biochemistry.

[15]  M. Palfreyman,et al.  Haloallylamine inhibitors of MAO and SSAO and their therapeutic potential. , 1994, Journal of neural transmission. Supplementum.

[16]  H. Yamaguchi,et al.  Crystal structures of the copper-containing amine oxidase from Arthrobacter globiformis in the holo and apo forms: implications for the biogenesis of topaquinone. , 1998, Biochemistry.

[17]  G. Kleywegt,et al.  Structure of human semicarbazide-sensitive amine oxidase/vascular adhesion protein-1. , 2005, Acta crystallographica. Section D, Biological crystallography.

[18]  T. Tojo,et al.  Synthesis and SAR study of new thiazole derivatives as vascular adhesion protein-1 (VAP-1) inhibitors for the treatment of diabetic macular edema. , 2013, Bioorganic & medicinal chemistry.

[19]  M. Palcic,et al.  A continuous spectrophotometric assay for monoamine oxidase and related enzymes in tissue homogenates. , 1997, Analytical biochemistry.

[20]  V. Calderone,et al.  Crystal structure of amine oxidase from bovine serum. , 2005, Journal of molecular biology.

[21]  J. Jaume,et al.  Diabetes-Associated Dry Eye Syndrome in a New Humanized Transgenic Model of Type 1 Diabetes , 2013, Molecular vision.

[22]  Wladek Minor,et al.  HKL-3000: the integration of data reduction and structure solution--from diffraction images to an initial model in minutes. , 2006, Acta crystallographica. Section D, Biological crystallography.

[23]  P. Dunkel,et al.  Semicarbazide-sensitive amine oxidase/vascular adhesion protein-1: a patent survey , 2011, Expert opinion on therapeutic patents.

[24]  S. Jalkanen,et al.  Cloning of  Vascular Adhesion Protein 1 Reveals a Novel Multifunctional Adhesion Molecule , 1998, The Journal of experimental medicine.

[25]  Z. Otwinowski,et al.  [20] Processing of X-ray diffraction data collected in oscillation mode. , 1997, Methods in enzymology.

[26]  A. Cohen,et al.  The crystal structure of Pichia pastoris lysyl oxidase. , 2003, Biochemistry.

[27]  T. Kappe,et al.  Pyridazines with heteroatom substituents in positions 3 and 5. 6. SN reactions in position 5 of 2‐aryl‐5‐hydroxypyridazin‐3(2H)‐ones , 1990 .

[28]  M. R. Parsons,et al.  Crystal structure of a quinoenzyme: copper amine oxidase of Escherichia coli at 2 A resolution. , 1995, Structure.

[29]  J. Fernández-Recio,et al.  New efficient substrates for semicarbazide-sensitive amine oxidase/VAP-1 enzyme: analysis by SARs and computational docking. , 2006, Journal of medicinal chemistry.

[30]  Gary Peltz,et al.  Can 'humanized' mice improve drug development in the 21st century? , 2013, Trends in pharmacological sciences.

[31]  S. Lang,et al.  New synthesis of 1,2,4-triazoles and 1,2,4-oxadiazoles , 1979 .

[32]  David Smith,et al.  Crystallization and preliminary X-ray analysis of the human vascular adhesion protein-1. , 2003, Acta crystallographica. Section D, Biological crystallography.

[33]  Z. Otwinowski,et al.  research papers Acta Crystallographica Section A Foundations of , 2003 .

[34]  Vimal Parkash,et al.  Structural comparison of the active site channels in rodent and primate vascular adhesion protein-1 , 2013, Journal of Neural Transmission.

[35]  O. Pentikäinen,et al.  Novel hydrazine molecules as tools to understand the flexibility of vascular adhesion protein-1 ligand-binding site: toward more selective inhibitors. , 2011, Journal of medicinal chemistry.

[36]  David J Smith,et al.  Identification of two imidazole binding sites and key residues for substrate specificity in human primary amine oxidase AOC3. , 2011, Biochemistry.

[37]  P. Yin,et al.  The discovery and development of selective 3-fluoro-4-aryloxyallylamine inhibitors of the amine oxidase activity of semicarbazide-sensitive amine oxidase/vascular adhesion protein-1 (SSAO/VAP-1). , 2012, Bioorganic & medicinal chemistry letters.

[38]  M. Orozco,et al.  Exploring the binding mode of semicarbazide-sensitive amine oxidase/VAP-1: identification of novel substrates with insulin-like activity. , 2004, Journal of medicinal chemistry.

[39]  S. Jalkanen,et al.  Crystal structure of the human vascular adhesion protein‐1: Unique structural features with functional implications , 2005, Protein science : a publication of the Protein Society.

[40]  B. Mondovì,et al.  Copper Amine Oxidases : Structures, Catalytic Mechanisms and Role in Pathophysiology , 2009 .

[41]  Kevin Cowtan,et al.  research papers Acta Crystallographica Section D Biological , 2005 .

[42]  P. Yu,et al.  Characterization of human serum and umbilical artery semicarbazide-sensitive amine oxidase (SSAO). Species heterogeneity and stereoisomeric specificity. , 1994, Biochemical pharmacology.

[43]  V. Tumiatti,et al.  Synthetic polyamines as potential amine oxidase inhibitors: a preliminary study , 2011, Amino Acids.

[44]  T. Kappe,et al.  Pyridazines with heteroatom substituents in position 3 and 5. 3. 2-aryl-5-hydroxypyridazin-3(2H)-ones as potential herbicides: Synthesis and some reactions†‡ , 1989 .

[45]  L. Cendron,et al.  Multiple Binding Sites for Substrates and Modulators of Semicarbazide-Sensitive Amine Oxidases: Kinetic Consequences , 2008, Molecular Pharmacology.

[46]  O. Pentikäinen,et al.  Synthesis, in vitro activity, and three-dimensional quantitative structure-activity relationship of novel hydrazine inhibitors of human vascular adhesion protein-1. , 2010, Journal of medicinal chemistry.

[47]  A. W. Schüttelkopf,et al.  PRODRG: a tool for high-throughput crystallography of protein-ligand complexes. , 2004, Acta crystallographica. Section D, Biological crystallography.

[48]  P. Mátyus,et al.  Synthesis of 5H-pyridazino[4,5-b]indoles and their benzofurane analogues utilizing an intramolecular Heck-type reaction , 2004 .

[49]  R. Hotchkiss,et al.  Development of a new humanized mouse model to study acute inflammatory arthritis , 2012, Journal of Translational Medicine.